One phase two trial (mean age 58, with no upper age limit) demonstrated mean reduction in body weight of 15.6% in participants taking CagriSema, compared to 5.1% and 8.1% with semaglutide and cagrilintide in monotherapy, respectively, over 32 weeks
Say goodbye to bad hair days and hello to the confidence that comes with having a full, luscious head of hair
FIGURE 5 Biosensing and Diagnostics Biosensors can be described as analytical devices that measure changes in biological processes and convert them into a readable signal, such as electrical signals [ Among the exploited mechanisms in CQD-based biosensing is fluorescence quenching
Personalised Treatment Plans We recognise that each client's nutritional needs are unique
Balance exercises, controlled movements, sport-specific drills restore proprioception and coordination reducing future injury risk